INDICATION: Amyotrophic lateral sclerosis (ALS); musculoskeletal
In vitro, cell culture and fruit fly studies suggest promoting the expression of TNPO1 could help treat ALS caused by FUS mutations and multisystem proteinopathy caused by HNRNPA1 mutations. In vitro, TNPO1 decreased the formation of new toxic fibrils from...